Regulus Therapeutics
RGLS
#6993
Rank
NZ$0.98 B
Marketcap
NZ$14.27
Share price
0.00%
Change (1 day)
437.79%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$0.98 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of NZ$0.98 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.97 B445.4%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$203.98 B 20,544.61%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$45.51 B 4,506.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$212.83 B 21,439.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$551.75 B 55,739.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$199.71 B 20,111.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$0.19 B-80.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.20 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$73.95 B 7,385.07%๐Ÿ‡บ๐Ÿ‡ธ USA